Phase Ib Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HEC53856 Capsules in Patients With Non-dialysis Renal Anemia
Latest Information Update: 05 Jun 2023
At a glance
- Drugs HEC 53856 (Primary) ; Roxadustat
- Indications Anaemia
- Focus Adverse reactions
- Sponsors Sunshine Lake Pharma
- 17 Jun 2021 New trial record